[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@BiopharmIQ](/creator/twitter/BiopharmIQ) "Biotech Weekly News - Biggest Moves 6/12-6/16π π $KDNY XX% To acquire by #NVS & Ph1/2 data at ERA $AGRX XX% Increase Rx thru telemedicine $GRCL XX% Longer term follow-up data @ EHA 2023 $DERM XX% Topline data from Ph1 trial of DFD-29 $PRAX XX% Public Offering $0.95/share $VERV XX% Collab w/ $LLY on gene editing $ABOS XX% Topline results of ACU193 AAIC '23 $XFOR X% To join Russell 3000 index π $OMER -XX% Late breaking EHA presentation $CHRS -XX% To acquire $SURF $CRVS -XX% New data for CPI-818 $MRSN -XX% Partial clinical hold Check out the image for more detailsπΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1669814384007233540) 2023-06-16 21:09:07 UTC 25.7K followers, 4740 engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2/H1 2025. $DMAC Phase X $ACRS Phase 2a $ARCT Phase X $INMB Phase X $KPTI Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $PROK Phase X $SPRO Phase X $CRDL Phase X $ATAI Phase X $INMB Phase X $ACIU Phase X $IMRX Phase 2a Check out the image for more details πΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1939393482742960240) 2025-06-29 18:40:13 UTC 25.7K followers, 32.8K engagements "$ARCT ARCT-032 / Cystic Fibrosis / Phase X Safety findings No SAEs severe AEs or dose-limiting toxicities Dose-related increase in transient mild post-dose respiratory symptoms PK findings: Very low systemic exposure mRNA: all plasma specimens BLQ LNP lipid components sporadically detected in low concentrations (1.0 ng/mL) Prior results & Ph2 trial overview πΈ π 2/7"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258666174898389) 2025-07-15 23:06:21 UTC 25.7K followers, XXX engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2 2025 (1/2). $RVPH Phase X $VTGN Phase X $LLY Phase X $AGEN Phase X $GILD Phase X $IFRX Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $CADL Phase X $KPTI Phase X $ACLX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $XOMA Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $PRAX Phase 2b $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase 2"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1926707151835218050) 2025-05-25 18:29:16 UTC 25.7K followers, 31.6K engagements "$IONS Donidalorsen / Hereditary angioedema / PDUFA Robust Data Supports Potential Preferred Treatment for HAE Prophylaxis Sustained Reduction in HAE attacks that continue to improve with extended treatment Prior trial results πΈ π 3/7"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258672378298524) 2025-07-15 23:06:23 UTC 25.7K followers, XXX engagements "BPIQ Biotech Weekly Recap 4/17-4/21 π Top Pos. Moves: π $BLU XXX% $GSK acquired $GMDA XX% Omisirge approved $RXDX XX% $MRK acquired $STSA XX% $SNBL acquired $MTNB XX% Positive data @ECCMID ETFs: $XBI X% $IBB X% $IXIC -X% $INX X% $DJI 0%"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1649512830423425025) 2023-04-21 20:37:59 UTC 25.7K followers, 7887 engagements "π’ M&A News: Sanofi to acquire UK-based Vaccine Startup Vicebio πΈ $1.15B upfront + up to $450M in milestones. π§ͺ Adds early-stage RSV + hMPV combo vaccine candidate (VXB-241) and 'Molecular Clamp' tech to pipeline. β Molecular Clamp enables fully liquid fridge-stable vaccinesboosting efficiency distribution and prefilled syringe use. π Deal expected to close in Q4 2025 See image for more details π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947667718326653152) 2025-07-22 14:39:04 UTC 25.7K followers, 3416 engagements "𧬠Weekly Biotech Moves 7/14/25 - 7/18/25 $XBI: -XXXX% ($86.27) π΄ $IBB: -XXXX% ($129.73) π΄"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946342982334165050) 2025-07-18 22:55:02 UTC 25.7K followers, 3409 engagements "π Biotech Stock News 7/18 @ Open π $TELO XX% Telomir-1 Update in Prostate Cancer $MEIP XX% $100M Private Placement $NKGN X% NKGen Biotech and Hekabio Partnership $OCGN X% 1st Patient Dosed in GARDian3 Trial $CTXR X% Closing of $9M Offering $LXRX X% Patient-reported Data @ ASPN'25 $ELDN X% Tegoprubart Updated Ph1b Data $ZVRA -X% MIPLYFFA & OLPRUVA Presentations $AMRX -X% CREXONT NDS in Canada $BMY -X% Reblozyl Topline Ph3 Results $SPRY -X% EURneffy Approved in UK $VTRS -X% MR-139 Ph3 Update $BCLI -XX% Nasdaq Delisting & OTCQB Transition See the image and comments for more details πΈπ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946241617092128946) 2025-07-18 16:12:15 UTC 25.7K followers, 4402 engagements "π’ In case you missed it: Merck $MRK to Acquire Verona Pharma $VRNA πΈ Total transaction value $10B ($107 per ADS) π« Deal adds Ohtuvayre the first novel inhaled COPD treatment in XX years approved by FDA in June 2024 launched August 2024 with rapid U.S. uptake; also in trials for non-CF bronchiectasis β Closing expected Q4 2025 See image for more info π πΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943337784171008459) 2025-07-10 15:53:27 UTC 25.7K followers, 7283 engagements "π Biotech Stock News 7/11 @ Open $CVM XX% Partnership for Multikine in Cancer $DARE X% Receives $6M Grant for Drug Delivery $MIRA X% SKNY-1 Results Update $NKGN X% 1st Dose of Troculeucel Administered $BBIO X% Business Combination Update $IKNA -X% ISS and Glass Lewis Recommend Merger $VALN -X% IXCHIQ EMA Restriction Lifted $CAPR -XX% Deramiocel BLA Regulatory Update $MIST -XX% Pricing of $52.5M & CRL Acceptance See the image and comments for more details πΈπ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943715259401007353) 2025-07-11 16:53:24 UTC 25.7K followers, 4593 engagements "Biotech Weekly News: Biggest Moves 6/12-6/16πππ π’ $KDNY XX% To acquire by #NVS & Ph1/2 data at ERA $AGRX XX% Increase Rx thru telemedicine $GRCL XX% Longer term follow-up data @ EHA 2023 $DERM XX% Topline data from Ph1 trial of DFD-29 $PRAX XX% Public Offering $0.95/share $VERV XX% Collab w/ $LLY on gene editing $ABOS XX% Topline results of ACU193 AAIC '23 $XFOR X% To join Russell 3000 index π΄ $OMER -XX% Late breaking EHA presentation $CHRS -XX% To acquire $SURF $CRVS -XX% New data for CPI-818 $MRSN -XX% Partial clinical hold Check out the image for more detailsπΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1670146078891491330) 2023-06-17 19:07:09 UTC 25.7K followers, 3285 engagements "π Opaleye Management Q1 25* Holdings Released. π³ Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% π Top Holdings: $HROW $ETON $SNWV $LQDA $RYTM $CDXS $IMNM $TGTX $ARVN $OCUL $EWTX $TARA $DNA $GOSS $ANIK $PTGX $XOMA $TRVI $PVLA $GOSS *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details πΈπ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1923141090061976045) 2025-05-15 22:19:00 UTC 25.7K followers, 13.1K engagements "π RA Capital Q1 25* Holdings Released. π³ Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% π Top Holdings: $ASND $PCVX $RYTM $JANX $NAMS $ACLX $EWTX $RNA $WVE $ETNB $SPRY $SION $LENZ $DYN $TYRA $MLYS $GERN $RXST $BCAX $IRON *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details πΈ π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1923129186195210246) 2025-05-15 21:31:42 UTC 25.7K followers, 17.3K engagements "π€ How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above Based on Q1 XX HF data π $NRIX 8/34 π₯ $ACRS 7/34 π₯ $SRPT 7/34 π₯ $VRNA 7/34 π₯ $BEAM 6/34 π₯ Access our FREE screener to check your fave stocks π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946699938525860338) 2025-07-19 22:33:27 UTC 25.7K followers, 2069 engagements "Biotech Stock Catalyst Watchlist π Ph X data readouts this quarter (Q3): $ABOS ACU193 $PRTA PRX005 (anti-tau) $TSHA TSHA-102 $CORT Miricorilant $STOK STK-001 $DNLI DNL593 (TAK-594) $PASG PBGM01 (AAVhu68 viral vector) $GLPG GLPG5101 (CD19 CAR-T) $SQZ SQZ-eAPC-HPV $VBIV VBI-2901 $RVMD RMC-6236 (RASMULTI) $FIXX HMI-103 $IMVT IMVT-1402 $CGEM CLN-049 (Florentine) And more. Check out the image for moreπΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1679478999892860930) 2023-07-13 13:12:51 UTC 25.7K followers, 4277 engagements "π¨ X AdCom This Week π£ $GSK β― Blenrep combinations (BVd & BPd) AdCom: July XX 2025 π Indication: Multiple myeloma BLA 761440 Plus X more July PDUFAs ahead Catch the full rundown in our last post π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944859330135908829) 2025-07-14 20:39:32 UTC 25.7K followers, 13.5K engagements "𧬠Biotech Weekly News 04/21/25 - 04/25/25 Major Movers π π $RZLT XX% Positive Recommendation Ph3 sunRIZE Study $SMMT XX% Ivonescimab Shows Superiority in NSCLC $HCM XX% Completed Enrollment Ph2 Registrational Study $TLSA XX% Initiated Dosing Ph2 Intranasal Foralumab Trial $BCAX XX% Updated Data from Phase 1/1b Trial $COEP -XX% Announced Merger Agreement $INTS -XX% $2.35M Public Offering $VYNE -XX% Update on VYN202 Program $IBIO -XX% Licensing of Antibody from AstralBio $BCTX -XX% Pricing of $13.8M Offering $4.50/share See image below. πΈ π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1915897685028311510) 2025-04-25 22:36:18 UTC 25.7K followers, 6414 engagements "π‘ July Biotech PDUFA Pulse: Whats on the FDA Radar π $REGN: Lynozyfic - Approved β $RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat - Approved β Check out the July PDUFA calendar. π π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942310016897122648) 2025-07-07 19:49:29 UTC 25.7K followers, 32.6K engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2 2025 (1/2). $GILD Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $IMNN Phase X $CADL Phase X $ANAB Phase 2b $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $SRRK Phase X $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase 2"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1929249038509261037) 2025-06-01 18:49:49 UTC 25.7K followers, 26.1K engagements "π Biotech Stock News 07/03 @ Open𧬠π° $LIXT XX% Closing of $5M Placement $THTX XX% Acquired by CB Biotechnology $CLRB X% Closing of $6.9M Offering $OSTX X% End of Phase X Meeting Granted $VRTX X% Present Longer-Term Data on CASGEVY at EHA $ELAN X% Global Licensing Agreement for NUZ-001 Commercialisation $OGEN -X% Completes $16.5M Offering $NVS -X% Update on Ph3 GCAptAIN Study $FDMT -X% Accelerated 4D-150 Ph3 Development $DYN -X% Closing of Public Offering $NKTR -X% Closing of $115M Offering $IMAB -X% Positive Givastomig Ph1b Data $BCAB -X% Data from BA3182 Dose Escalation $INO -XX% Pricing"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940799830961602886) 2025-07-03 15:48:32 UTC 25.7K followers, 2980 engagements "Don't miss out on future PDUFAs & AdComs π― π PDUFA events: groundbreaking stock milestones β¨ often trigger major stock movements π ideal for trading & options strategies πΈ Access our free PDUFA Report to see more info π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942310019388551380) 2025-07-07 19:49:29 UTC 25.7K followers, 8356 engagements "Breast Cancer Catalyst Watchlistπ¬ Exciting catalyst events happening this yearπ $SYRS Ph2 $ATNX Ph2 $PBYI Ph2 $IMGN Ph1 $IMV Ph1b $AMAM Ph2/3 $PRLD Ph1 Even more catalyst events this year. $NXTC $ARVN $CRDF $ADAP Check out the image for more detailsπΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1668629738242596868) 2023-06-13 14:41:45 UTC 25.7K followers, 3891 engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CRDF Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $INMB Phase X $IFRX Phase 2a"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036716457754997) 2025-07-20 20:51:42 UTC 25.7K followers, 30.7K engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2 2025 (1/2). $JAZZ Phase X $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $SRRK Phase X $ACRS Phase 2a $NKTR Phase 2b $CMPS Phase X $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $VIR Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $EGRX Phase 2/3 Check out the image for more details πΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1931775707870626066) 2025-06-08 18:09:54 UTC 25.7K followers, 35.8K engagements "π£ Biotech Stock News 07/08 @ Open 𧬠π° $PROK XXX% Topline Results for Phase X Trial $ZVSA XX% Supports FDA Emergency Use of VAR XXX $RLYB XX% Sells Interest in REV102 Program $PSTV XX% Initial Patients Treated in Dose Trial $HUMA XX% Symvess ECAT Approval from U.S. DLA $NBTX XX% Regulatory Harmonization and Patent Filed $RXRX XX% Acquires Full Rights to REV102 $LGVN X% FDA Approves IND for Pediatric DCM $ONCY X% Highlights Pelareorep Survival Data $LRMR X% Nonclinical Data on Nomlabofusp $RMTI X% Three-Year Partnership for Hemodialysis Supply $ETON X% FDA Accepts New Drug Application $CRGX"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942601154040586416) 2025-07-08 15:06:21 UTC 25.7K followers, 4101 engagements "𧬠Biopharma Weekly Recap π Interesting posts/ppl to check out π @BowTiedBiotech 1/ π« Mercks $10B Verona Bet: A Biotech Thread @Andre_AGTC $VRNA aquisition has positive effect on bios which are potential BO candidates $MDGL $MIRM $BBIO $SRRK $CRNX @JacobPlieth $VRNAs Enfisentirine Composition Patent Expired in 2020 Not a Concern for $MRK @LifeSciVC $MRK will acquire Verona Pharma $VRNA for $10B. Fun bit of biotech history. @A_May_MD Parallels Between $NKTR and $VRNA: Early-Stage Setup Market Potential and Sentiment Dynamics @doepke_michel $MDGL Positioned as Potential Takeover Target"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944102553324863581) 2025-07-12 18:32:23 UTC 25.7K followers, 13.9K engagements "π Biotech Stock News 7/7 @ Open 𧬠π° $COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses $URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling $NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -2%"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942253838402289849) 2025-07-07 16:06:15 UTC 25.7K followers, 3437 engagements "$ONC FDA approves tablet formulation of BRUKINSA (zanubrutinib) for all X approved indications π New tablets reduce pill burden & simplify dosing without compromising efficacy or safety β Proven bioequivalent to capsules via Phase X crossover studies π Only BTK inhibitor offering flexible once or twice daily dosing π©Ί Only BTK inhibitor with recommended dosing for severe hepatic impairment BRUKINSA leads new CLL patient starts & is now top BTK inhibitor by U.S. market share See image for more details π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1933248489976418379) 2025-06-12 19:42:12 UTC 25.7K followers, 2537 engagements "July PDUFA Approval Decision Calendar Approval decisions for: $REGN $RHHBY $REPL $ASND $APLS $PTCT $KALV See details in our PDUFA calendar π π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1939694731447202150) 2025-06-30 14:37:16 UTC 25.7K followers, 23.4K engagements "π Biotech Stock News 07/16 @ Open 𧬠π° $CGTX XX% Clinical Data from Ph2 Study $ONCY X% Aggregated Data on Pelareorep Effectiveness $CUE X% Complete Response Data in Ph1 Trial $RPTX X% Licensing Agreement for Lunresertib $VYGR X% Adds Fourth Alzheimer's Program to Pipeline $ADIL X% Regains Compliance with Nasdaq $KALV X% UK Approval of HAE Treatment $OGEN X% Manufacturing Agreement for ONP-002 Development $TMO -X% Strategic Partnership for Drug Manufacturing $BCDA -X% Patient Enrollment for CardiAMP HF Study $ENSC -X% Initiates Ph3 Study of PF614 $QNCX -X% Completes Enrollment in Phase 3"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945517869774848275) 2025-07-16 16:16:20 UTC 25.7K followers, 2666 engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q3 2025. $PHVS Phase X $PHVS Phase X $NAMS Phase 2a $CGTX Phase X $DMAC Phase X $COGT Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $APGE Phase X $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase 3"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1941929261340016921) 2025-07-06 18:36:29 UTC 25.7K followers, 48.7K engagements "𧬠Biotech Weekly News 7/14/25 - 7/18/25 Major Movers π π $TELO XX% Telomir-1 Update in Prostate Cancer $KAPA XX% Positive Results from Ph2 Trial $MEIP XX% $100M Private Placement $DARE XX% Ovaprene Interim Ph3 Results $RCKT XX% Receives RMAT Designation for Gene Therapy $SRPT -XX% FDA Shipment Halt Warning for Elevidys $CLSD -XX% Explore Strategic Alternatives for SCS Platform $BCLI -XX% Nasdaq Delisting & OTCQB Transition $ABOS -XX% Strategic Collab. for Alzheimer's Therapy $IKNA -X% Stockholder Approval of Merger See image below. πΈ π¨ $SRPT closed down XX% after reports of 3rd gene"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946342699277418706) 2025-07-18 22:53:55 UTC 25.7K followers, 7191 engagements "Interested in finding companies before they announce M&As πβ See our free M&A whispers report & see which could be next π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947667722948727175) 2025-07-22 14:39:05 UTC 25.7K followers, 1153 engagements "Check out our catalyst calendar π & stay on top of key biopharma readouts π π $XBI $IBB"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943792156818456756) 2025-07-11 21:58:58 UTC 25.7K followers, 1243 engagements "VR Adviser LLC-Bio Hedge Fund Q1 Holdings Top Holdings: $VRDN $COGT $ELVN $TERN $PLRX $AMAM $GHRS $DICE $KALV $MRUS $CELC $AVTE $CABA $VECT $ANNX $SVRA $MIST $ACRS $THRX $TRVI $FULC More details in the image:"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1658228884087664640) 2023-05-15 21:52:29 UTC 25.7K followers, 2968 engagements "Biotech News 4/17π° $RXDX XX% Acquired by $MRK $XXXX B $STSA XX% Acquired by $SNBL $PCVX XX% Ph2 &Ph1/2 data $PIRS XX% Ph1 data @AACR'23 $MRUS XX% Ph1/2 interim data $PRAX X% Upcoming data presentations $CRVS X% New data @AACR'23 $INO X% Ph1b data @ECCMID'23 $ACAD X% Commercial Launch $AFMD X% Ph2 final data @AACR'23 $RNA X% Data upcoming @AAN'23 $XBIT X% Enrolled in Ph1 $VACC X% Ph1/2 interim data $ABCL X% New data @AACR'23 $MOR -X% Ph2 data @AACR'23 $IFRX -X% $40M Offering $GRTS -X% Ph1 data @ECCMID'23 $ALLO -X% Interim data @AACR'23 $AXLA -X% Ph2 Data @ECCMID'23 $XBI $XXXX XXX% $IBB $133.2"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1648020924107464704) 2023-04-17 17:49:41 UTC 25.7K followers, XX engagements "𧬠Weekly Biotech Moves 7/7/25 - 7/11/25 $XBI: XXXX% ($87.02) π’ $IBB: XXXX% ($131.59) π’"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943792153345634443) 2025-07-11 21:58:57 UTC 25.7K followers, 2430 engagements "π’ M&A News: Theratechnologies $THTX Acquired by CB Biotechnology for up to $254M π€ π΅ $3.01/sh in cash + up to $1.19/sh CVR π $THTX up XX% at open π Expected to close during the Companys Q4 ending November XX 2025. See more information π πΈ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940783121408184781) 2025-07-03 14:42:08 UTC 25.7K followers, 10.8K engagements "1/ π¨ $GSK AdCom is tomorrow 7/17 π§΅ π Belantamab mafodotin for r/r multiple myeloma β Ahead of meeting FDA raised safety concerns: π π© High rates of ocular toxicity incl. corneal damage & vision loss In DREAMM-7 & DREAMM-8: πΈ XX% of patients had eye toxicity (KVA events) πΈ 7778% had Grade XX events πΈ 70%+ had recurrent eye issues πΈ XX% still had unresolved eye toxicity at cutoff πΈ 7678% needed dose mods due to eye toxicity π© Dosing under fire: πΈ High toxicity despite adjusted regimens (2.5 mg/kg vs. XXX mg/kg) πΈ XX% remained on intended dose by Cycle X πΈ Limited dose optimization"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945611449659007077) 2025-07-16 22:28:11 UTC 25.7K followers, 12.5K engagements "π€ How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above $SRRK 8/34 π₯ $VRNA 7/34 π₯ $CRNX 7/34 π₯ $MDGL 6/34 π₯ $BPMC 5/34 π $PRME 5/34 π Access our FREE screener to check your fave stocks π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944103754133123373) 2025-07-12 18:37:09 UTC 25.7K followers, 3087 engagements "𧬠Weekly Biotech Moves 6/30/25 - 7/3/25 $XBI: XXXX% ($85.24) π’ $IBB: XXXX% ($130.00) π’"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1941193952910295188) 2025-07-04 17:54:38 UTC 25.7K followers, 3514 engagements "Biotech Stock News 5/22 Mid-day π $HEPA XX% Positive Ph2 result #NASH $AVRO XX% Sale of Gene therapy program to Novartis $87.5M $VECT XX% Acquisition by $IRWD $17.00/share $AKBA XX% UK approval $KRYS XX% $160M private placement $INKT XX% Data presentation @ ATS 2023 $PSTX XX% Data Presentation @ISTH 2023 $AUTL X% Ph2 data @ASCO 2023 $ALPN X% Ph1 data @major conferences $IDYA X% IND cleared $CYTK X% New data @ International congress $ATNM X% Poster presentation @SNMMI 2023 $RYTM X% Collaboration w/Genpharm $XBIT X% Ph2 study authorized $BBIO X% Updated data @ASGCT 2023 $KRTX X% Data"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1660698671141273624) 2023-05-22 17:26:32 UTC 25.7K followers, 4952 engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944458773806149859) 2025-07-13 18:07:52 UTC 25.7K followers, 33.9K engagements "$FBIO β CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA Showed significant clinical benefit in both CuHis-ET (early tx) and CuHis-LT (late tx) cohorts 75-79% reduction in risk of death compared to untreated Historical Control (HC-ET and HC-LT) arms increase in Median OS from XXX years to XXXX years in the ET cohort Prior results πΈ π 4/7"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258677990252701) 2025-07-15 23:06:24 UTC 25.7K followers, XXX engagements "Each quarter we identify major catalyst events π₯³ Likely to move the stock +/- by XX% π π $MLTX Sonelokimab $LRMR Nomlabofusp (CTI-1601) $IFRX INF904 Access our FREE Big Mover Report π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036720882713048) 2025-07-20 20:51:43 UTC 25.7K followers, XXX engagements "π Baker Bros. Q1 25* Holdings Released. π³ Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXX% π Top Holdings: $ONC $INCY $ACAD $MDGL $SMMT $INSM $RYTM $RVMD $KYMR $ALKS $EWTX $REPL $INSM $IMVT $BCYC $IMCR $KNSA $ABCL $RARE $DNLI *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details πΈπ"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1923137621208997937) 2025-05-15 22:05:13 UTC 25.7K followers, 20.7K engagements "6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts in Q3 XX π π See π§΅ for more details about each asset/readout π $ARCT (Mid-2025) ARCT-032 / Cystic Fibrosis / Phase X $IONS (August XX 2025) Donidalorsen / Hereditary angioedema / PDUFA $FBIO (September XX 2025) β CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA $KALA (Q3 2025) KPI-012 / Persistent Corneal Epithelial Defect / Phase 2b $HRMY (Q3 2025) Zygel (ZYN002 CBD Gel) / Fragile X syndrome / Phase X $LRMR (September 2025) β Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X β = Expected big stock move confirmed by"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258659799556112) 2025-07-15 23:06:20 UTC 25.7K followers, 8833 engagements "Let's see how many of the XX biopharma-focused hedge funds hold these tickers (5 is π₯). $MLTX 7/34 π₯ $LRMR 4/34 $IFRX 1/34 Access our FREE hedge fund screener & search your fav tickers π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036722971451839) 2025-07-20 20:51:43 UTC 25.7K followers, XXX engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q4 2024 (1/4). $IMMP Phase X $AVIR Phase X $ABUS Phase 2a $ABUS Phase 2a $BRNS Phase 2b $VIR Phase X $DRRX Phase 2b $PLRX Phase 2a $AKRO Phase 2b $CRDL Phase X $ALGS Phase 2a $SYRS Phase X $IKT Phase X $ANAB Phase 2b $BMEA Phase 2b $GALT Phase 2b/3 $BMEA Phase X $MRUS Phase X $KROS Phase X $ADCT Phase X $AFMD Phase X $COGT Phase X $HCM Phase X $ADCT Phase X $SLS Phase 2a $AGIO Phase X $KROS Phase X $COGT Phase X $GLYC Phase X $LLY Phase X $ACLX Phase X $CLRB Phase X $LLY Phase X $BCTX Phase X $JAGX Phase X Check out the image for"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1855705848456376350) 2024-11-10 20:15:26 UTC 25.7K followers, 17.2K engagements "Each quarter we identify major catalyst events π₯³ Likely to move the stock XX% or more π π $KZIA Paxalisib Ph2/3 $ATAI RL-007 Ph2b $CRNX Paltusotine PDUFA $INMB INKmune Ph2 and more π Access our FREE Big Mover Report π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946343944239059319) 2025-07-18 22:58:52 UTC 25.7K followers, 1641 engagements "Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2/H1 2025. $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $ARCT Phase X $PROK Phase X $ANRO Phase X $SPRO Phase X $INMB Phase X $CRDL Phase X $ATAI Phase X $INMB"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1936859643827098049) 2025-06-22 18:51:38 UTC 25.7K followers, 20.6K engagements "π£ Biotech Stock News 07/17 @ Open $SRPT XX% Strategic Restructuring & Pipeline Update $RCKT XX% Receives RMAT Designation for Gene Therapy $MBRX XX% Explores Accelerated Strategic Partnerships $DMAC X% Positive Interim Phase X Results $MAIA X% Peer-Reviewed Pub. on Anticancer Prodrugs $AGEN X% FDA Approves SHINGRIX Prefilled Syringe $XXII X% Launch Confirms Viability of Nicotine Mandate $DNA X% Launches ADME Profiling Service $SDGR X% Expand Research Collaboration on JAK Target $PRAX X% FDA Breakthrough Therapy for Relutrigine $CYBN X% UK Approval for EMBRACE Study $NKGN X% New Funding for"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945871031148876231) 2025-07-17 15:39:41 UTC 25.7K followers, 9530 engagements "1/ π¨ PDUFA Pulse: π Whats on the FDA Radar This July π $REGN: Lynozyfic Approved β $RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat Check out the July PDUFA calendar. π π π‘ Cantor initiates coverage on $REPL ahead of July XX PDUFA full context below from @Quantumup1"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940499624751734957) 2025-07-02 19:55:37 UTC 25.7K followers, 21.7K engagements "$GSK π£ FDAs ODAC votes against belantamab mafodotin combos in R/R multiple myeloma β XX vote against BVd (with bortezomib) πππππ vs. πππ β XX vote against BPd (with pomalidomide) πππππππ vs. π β Reason: High ocular toxicity & poor tolerability despite PFS gains in DREAMM-7/8 FDA questioned dosage selection & real-world relevance of trial data Committee urged exploration of lower more tolerable doses π A tough call: Strong efficacy but stronger toxicity concerns"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945960037979242732) 2025-07-17 21:33:21 UTC 25.7K followers, 5640 engagements "$LRMR β Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X Generally well tolerated Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells) FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing Prior results πΈ π 7/7"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258697317605760) 2025-07-15 23:06:29 UTC 25.7K followers, 2099 engagements "$GSK $AGEN π FDA approves GSKs SHINGRIX in a prefilled syringe Simplifies administration no vial reconstitution needed π Based on data showing technical comparability to current 2-vial version Supports easier delivery for healthcare professionals π― 1M people develop shingles in the US annually"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945892628165476838) 2025-07-17 17:05:30 UTC 25.7K followers, 3770 engagements "Biotech News 6/29 @ close π $SGTX XXX% Acquire by $LLY $14.92/sh $ENDPQ XX% Generic launch $FBIO X% Ph1 Dotinurad data $SGMO X% Licensing agrmnt w/ VYGR $MRUS X% BTD granted $ALDX X% Ph2 ADX2191 data $MNOV X% Presentation at RSA $LLY X% Acquire $SGTX $IRWD X% Completion of tender offer $BNTX X% Initiate Ph3 $AQST X% Submitted Libervant NDA $VECT X% Completion of tender offer $AZN X% Liver cancer ph3 data $AUPH X% Strategic alternatives (sale) $PTCT -X% Data from MIT-E $GERN -X% Expanded access $AKBA -X% Ph4 IMPACT data $PSTV -X% Interim updates $VYGR -X% Licensing agrmnt w/ $SGMO $CRVS -5%"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1674529403815043073) 2023-06-29 21:24:55 UTC 25.7K followers, 12.5K engagements "Each quarter we identify major catalyst events π₯³ Likely to move the stock +/- by XX% π π Prev. Qtr Movers: π’ $LYRA XXXXXX% π’ $NKTR XXXXXX% π΄ $IFRX -XXXXX% π΄ $PRTA -XXXXX% Access our free Big Mover Report π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258700966408234) 2025-07-15 23:06:30 UTC 25.7K followers, 2164 engagements "Each quarter we identify major catalyst events π₯³ Likely to move the stock XX% or more π π $KZIA Paxalisib Ph2/3 $ATAI RL-007 Ph2b $CRNX Paltusotine PDUFA and more π Access our FREE Big Mover Report π"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1941196214466380236) 2025-07-04 18:03:37 UTC 25.7K followers, 1635 engagements "π Biotech Stock News 7/14 @ Open $DARE XX% Ovaprene Interim Phase X Results $RANI XX% Bioequivalence of Novel Oral Agonist $EPIX X% Acquired by Xenotherapeutics $AMLX X% New Analyses from Ph2 Trials $CRNX X% New Long-Term Data on Paltusotine $VSTM X% Publication of Ph2 RAMP XXX Results $GILD X% New Data on Lenacapavir for HIV $RYTM X% Data on MC4R Agonists at ENDO 2025 $NBIX X% One-Year Data on CRENESSITY Efficacy $RARE X% Approval Extended for HoFH Treatment $RARE X% CRL for UX111 AAV Gene Therapy $PHGE X% Ph2b Trial for BX004 Initiated $CORT X% NDA for Relacorilant $CELC X% New Patent for"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944795798333755837) 2025-07-14 16:27:05 UTC 25.7K followers, 3801 engagements "Biotech Stock News 8/8 @ Open π $CRDF XX% Lead program update $INAB X% R&D facility $AMRN X% Commercial agreement $COCP X% Norovirus lead selected $JAGX X% Partners IND $RXRX X% Protein target prediction $ONCY -X% $15M public offering $EOLS -X% New Jeuveau branding $LSTA -X% ODD granted $PRAX -X% Long-term data $EBS -X% Cost reduction Full #biotech news in image below: π·"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1688945353154789377) 2023-08-08 16:08:45 UTC 25.7K followers, 3632 engagements "π£ Biotech Stock News 07/15 @ Open 𧬠π° $KAPA XX% Positive Safety Results from Phase X Trial $PROK X% Alignment with FDA on Approval Pathway $LSTA X% Expands Intellectual Property Portfolio $CTXR X% Expands Distribution Network for LYMPHIR $CVM X% Closing of $XXX Million Offering $SLS X% Meets Primary Endpoints in Phase X Trial $ADAG X% Regulatory Update on Clinical Development $ATRA X% Transfer of Investigational New Drug Application $AEMD X% Positive Data Review for Next Trial $AQST X% International Expansion Update for Anaphylm $PYPD -X% Long-Acting GLP-1 Delivery Platform $GH -X% First"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945152036066222141) 2025-07-15 16:02:39 UTC 25.7K followers, 4572 engagements "𧬠Biopharma Weekly Recap π Interesting posts/ppl to check out π @ohadhammer New Jefferies Report Explores Chinas Biotech Ecosystem @BowTiedBiotech Great figure from Oppenheimer team on The China Trade @BioStocks $MDGL Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra. @seedy19tron Oral hearing for the $NKTR $LLY case @GeneInvesting REMEMBER $NTLA @yaireinhorn David Liu Warns of Impact from NIH Funding Cuts on U.S. Science @Prof_Oak_ $PRME proposing to reprice 8.3M options on the back of a 300%+ bounce from May lows @adamfeuerstein Leadership"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946699121982943514) 2025-07-19 22:30:13 UTC 25.7K followers, 16.7K engagements "π£ Biotech Stock News 07/22 @ Open $CRDL XX% Database Lock for Phase X Trial $CNTB XX% Appoints Industry Veteran to Board $STRO X% Research Collab. to Advance Standards $CGEM X% Acceptance of Abstracts for Zipalertinib $BIIB X% Highlighting Progress in Alzheimer's Disease $EHTH X% Achieves HITRUST i1 Certification $AZN X% Plans $50B investment in America $PCRX X% Strategic Collaboration to Expand Promotion $SRPT X% Voluntary Pause of ELEVIDYS Shipments $NAMS X% Presenting Alzheimer's Biomarker Data $DARE X% Webinar on DARE to PLAY Difference $OCUL X% Participation in Scientific Conferences"  [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947684863102095511) 2025-07-22 15:47:12 UTC 25.7K followers, 4181 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiopharmIQ
"Biotech Weekly News - Biggest Moves 6/12-6/16π π $KDNY XX% To acquire by #NVS & Ph1/2 data at ERA $AGRX XX% Increase Rx thru telemedicine $GRCL XX% Longer term follow-up data @ EHA 2023 $DERM XX% Topline data from Ph1 trial of DFD-29 $PRAX XX% Public Offering $0.95/share $VERV XX% Collab w/ $LLY on gene editing $ABOS XX% Topline results of ACU193 AAIC '23 $XFOR X% To join Russell 3000 index π $OMER -XX% Late breaking EHA presentation $CHRS -XX% To acquire $SURF $CRVS -XX% New data for CPI-818 $MRSN -XX% Partial clinical hold Check out the image for more detailsπΈ" @BiopharmIQ on X 2023-06-16 21:09:07 UTC 25.7K followers, 4740 engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2/H1 2025. $DMAC Phase X $ACRS Phase 2a $ARCT Phase X $INMB Phase X $KPTI Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $PROK Phase X $SPRO Phase X $CRDL Phase X $ATAI Phase X $INMB Phase X $ACIU Phase X $IMRX Phase 2a Check out the image for more details πΈ" @BiopharmIQ on X 2025-06-29 18:40:13 UTC 25.7K followers, 32.8K engagements
"$ARCT ARCT-032 / Cystic Fibrosis / Phase X Safety findings No SAEs severe AEs or dose-limiting toxicities Dose-related increase in transient mild post-dose respiratory symptoms PK findings: Very low systemic exposure mRNA: all plasma specimens BLQ LNP lipid components sporadically detected in low concentrations (1.0 ng/mL) Prior results & Ph2 trial overview πΈ π 2/7" @BiopharmIQ on X 2025-07-15 23:06:21 UTC 25.7K followers, XXX engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2 2025 (1/2). $RVPH Phase X $VTGN Phase X $LLY Phase X $AGEN Phase X $GILD Phase X $IFRX Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $CADL Phase X $KPTI Phase X $ACLX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $XOMA Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $PRAX Phase 2b $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase 2" @BiopharmIQ on X 2025-05-25 18:29:16 UTC 25.7K followers, 31.6K engagements
"$IONS Donidalorsen / Hereditary angioedema / PDUFA Robust Data Supports Potential Preferred Treatment for HAE Prophylaxis Sustained Reduction in HAE attacks that continue to improve with extended treatment Prior trial results πΈ π 3/7" @BiopharmIQ on X 2025-07-15 23:06:23 UTC 25.7K followers, XXX engagements
"BPIQ Biotech Weekly Recap 4/17-4/21 π Top Pos. Moves: π $BLU XXX% $GSK acquired $GMDA XX% Omisirge approved $RXDX XX% $MRK acquired $STSA XX% $SNBL acquired $MTNB XX% Positive data @ECCMID ETFs: $XBI X% $IBB X% $IXIC -X% $INX X% $DJI 0%" @BiopharmIQ on X 2023-04-21 20:37:59 UTC 25.7K followers, 7887 engagements
"π’ M&A News: Sanofi to acquire UK-based Vaccine Startup Vicebio πΈ $1.15B upfront + up to $450M in milestones. π§ͺ Adds early-stage RSV + hMPV combo vaccine candidate (VXB-241) and 'Molecular Clamp' tech to pipeline. β Molecular Clamp enables fully liquid fridge-stable vaccinesboosting efficiency distribution and prefilled syringe use. π
Deal expected to close in Q4 2025 See image for more details π" @BiopharmIQ on X 2025-07-22 14:39:04 UTC 25.7K followers, 3416 engagements
"𧬠Weekly Biotech Moves 7/14/25 - 7/18/25 $XBI: -XXXX% ($86.27) π΄ $IBB: -XXXX% ($129.73) π΄" @BiopharmIQ on X 2025-07-18 22:55:02 UTC 25.7K followers, 3409 engagements
"π Biotech Stock News 7/18 @ Open π $TELO XX% Telomir-1 Update in Prostate Cancer $MEIP XX% $100M Private Placement $NKGN X% NKGen Biotech and Hekabio Partnership $OCGN X% 1st Patient Dosed in GARDian3 Trial $CTXR X% Closing of $9M Offering $LXRX X% Patient-reported Data @ ASPN'25 $ELDN X% Tegoprubart Updated Ph1b Data $ZVRA -X% MIPLYFFA & OLPRUVA Presentations $AMRX -X% CREXONT NDS in Canada $BMY -X% Reblozyl Topline Ph3 Results $SPRY -X% EURneffy Approved in UK $VTRS -X% MR-139 Ph3 Update $BCLI -XX% Nasdaq Delisting & OTCQB Transition See the image and comments for more details πΈπ" @BiopharmIQ on X 2025-07-18 16:12:15 UTC 25.7K followers, 4402 engagements
"π’ In case you missed it: Merck $MRK to Acquire Verona Pharma $VRNA πΈ Total transaction value $10B ($107 per ADS) π« Deal adds Ohtuvayre the first novel inhaled COPD treatment in XX years approved by FDA in June 2024 launched August 2024 with rapid U.S. uptake; also in trials for non-CF bronchiectasis β
Closing expected Q4 2025 See image for more info π πΈ" @BiopharmIQ on X 2025-07-10 15:53:27 UTC 25.7K followers, 7283 engagements
"π Biotech Stock News 7/11 @ Open $CVM XX% Partnership for Multikine in Cancer $DARE X% Receives $6M Grant for Drug Delivery $MIRA X% SKNY-1 Results Update $NKGN X% 1st Dose of Troculeucel Administered $BBIO X% Business Combination Update $IKNA -X% ISS and Glass Lewis Recommend Merger $VALN -X% IXCHIQ EMA Restriction Lifted $CAPR -XX% Deramiocel BLA Regulatory Update $MIST -XX% Pricing of $52.5M & CRL Acceptance See the image and comments for more details πΈπ" @BiopharmIQ on X 2025-07-11 16:53:24 UTC 25.7K followers, 4593 engagements
"Biotech Weekly News: Biggest Moves 6/12-6/16πππ π’ $KDNY XX% To acquire by #NVS & Ph1/2 data at ERA $AGRX XX% Increase Rx thru telemedicine $GRCL XX% Longer term follow-up data @ EHA 2023 $DERM XX% Topline data from Ph1 trial of DFD-29 $PRAX XX% Public Offering $0.95/share $VERV XX% Collab w/ $LLY on gene editing $ABOS XX% Topline results of ACU193 AAIC '23 $XFOR X% To join Russell 3000 index π΄ $OMER -XX% Late breaking EHA presentation $CHRS -XX% To acquire $SURF $CRVS -XX% New data for CPI-818 $MRSN -XX% Partial clinical hold Check out the image for more detailsπΈ" @BiopharmIQ on X 2023-06-17 19:07:09 UTC 25.7K followers, 3285 engagements
"π Opaleye Management Q1 25* Holdings Released. π³ Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% π Top Holdings: $HROW $ETON $SNWV $LQDA $RYTM $CDXS $IMNM $TGTX $ARVN $OCUL $EWTX $TARA $DNA $GOSS $ANIK $PTGX $XOMA $TRVI $PVLA $GOSS *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details πΈπ" @BiopharmIQ on X 2025-05-15 22:19:00 UTC 25.7K followers, 13.1K engagements
"π RA Capital Q1 25* Holdings Released. π³ Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% π Top Holdings: $ASND $PCVX $RYTM $JANX $NAMS $ACLX $EWTX $RNA $WVE $ETNB $SPRY $SION $LENZ $DYN $TYRA $MLYS $GERN $RXST $BCAX $IRON *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details πΈ π" @BiopharmIQ on X 2025-05-15 21:31:42 UTC 25.7K followers, 17.3K engagements
"π€ How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above Based on Q1 XX HF data π $NRIX 8/34 π₯ $ACRS 7/34 π₯ $SRPT 7/34 π₯ $VRNA 7/34 π₯ $BEAM 6/34 π₯ Access our FREE screener to check your fave stocks π" @BiopharmIQ on X 2025-07-19 22:33:27 UTC 25.7K followers, 2069 engagements
"Biotech Stock Catalyst Watchlist π Ph X data readouts this quarter (Q3): $ABOS ACU193 $PRTA PRX005 (anti-tau) $TSHA TSHA-102 $CORT Miricorilant $STOK STK-001 $DNLI DNL593 (TAK-594) $PASG PBGM01 (AAVhu68 viral vector) $GLPG GLPG5101 (CD19 CAR-T) $SQZ SQZ-eAPC-HPV $VBIV VBI-2901 $RVMD RMC-6236 (RASMULTI) $FIXX HMI-103 $IMVT IMVT-1402 $CGEM CLN-049 (Florentine) And more. Check out the image for moreπΈ" @BiopharmIQ on X 2023-07-13 13:12:51 UTC 25.7K followers, 4277 engagements
"π¨ X AdCom This Week π£ $GSK β― Blenrep combinations (BVd & BPd) AdCom: July XX 2025 π
Indication: Multiple myeloma BLA 761440 Plus X more July PDUFAs ahead Catch the full rundown in our last post π" @BiopharmIQ on X 2025-07-14 20:39:32 UTC 25.7K followers, 13.5K engagements
"𧬠Biotech Weekly News 04/21/25 - 04/25/25 Major Movers π π $RZLT XX% Positive Recommendation Ph3 sunRIZE Study $SMMT XX% Ivonescimab Shows Superiority in NSCLC $HCM XX% Completed Enrollment Ph2 Registrational Study $TLSA XX% Initiated Dosing Ph2 Intranasal Foralumab Trial $BCAX XX% Updated Data from Phase 1/1b Trial $COEP -XX% Announced Merger Agreement $INTS -XX% $2.35M Public Offering $VYNE -XX% Update on VYN202 Program $IBIO -XX% Licensing of Antibody from AstralBio $BCTX -XX% Pricing of $13.8M Offering $4.50/share See image below. πΈ π" @BiopharmIQ on X 2025-04-25 22:36:18 UTC 25.7K followers, 6414 engagements
"π‘ July Biotech PDUFA Pulse: Whats on the FDA Radar π $REGN: Lynozyfic - Approved β
$RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat - Approved β
Check out the July PDUFA calendar. π
π" @BiopharmIQ on X 2025-07-07 19:49:29 UTC 25.7K followers, 32.6K engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2 2025 (1/2). $GILD Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $IMNN Phase X $CADL Phase X $ANAB Phase 2b $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $SRRK Phase X $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase 2" @BiopharmIQ on X 2025-06-01 18:49:49 UTC 25.7K followers, 26.1K engagements
"π Biotech Stock News 07/03 @ Open𧬠π° $LIXT XX% Closing of $5M Placement $THTX XX% Acquired by CB Biotechnology $CLRB X% Closing of $6.9M Offering $OSTX X% End of Phase X Meeting Granted $VRTX X% Present Longer-Term Data on CASGEVY at EHA $ELAN X% Global Licensing Agreement for NUZ-001 Commercialisation $OGEN -X% Completes $16.5M Offering $NVS -X% Update on Ph3 GCAptAIN Study $FDMT -X% Accelerated 4D-150 Ph3 Development $DYN -X% Closing of Public Offering $NKTR -X% Closing of $115M Offering $IMAB -X% Positive Givastomig Ph1b Data $BCAB -X% Data from BA3182 Dose Escalation $INO -XX% Pricing" @BiopharmIQ on X 2025-07-03 15:48:32 UTC 25.7K followers, 2980 engagements
"Don't miss out on future PDUFAs & AdComs π― π PDUFA events: groundbreaking stock milestones β¨ often trigger major stock movements π ideal for trading & options strategies πΈ Access our free PDUFA Report to see more info π" @BiopharmIQ on X 2025-07-07 19:49:29 UTC 25.7K followers, 8356 engagements
"Breast Cancer Catalyst Watchlistπ¬ Exciting catalyst events happening this yearπ
$SYRS Ph2 $ATNX Ph2 $PBYI Ph2 $IMGN Ph1 $IMV Ph1b $AMAM Ph2/3 $PRLD Ph1 Even more catalyst events this year. $NXTC $ARVN $CRDF $ADAP Check out the image for more detailsπΈ" @BiopharmIQ on X 2023-06-13 14:41:45 UTC 25.7K followers, 3891 engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CRDF Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $INMB Phase X $IFRX Phase 2a" @BiopharmIQ on X 2025-07-20 20:51:42 UTC 25.7K followers, 30.7K engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2 2025 (1/2). $JAZZ Phase X $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $SRRK Phase X $ACRS Phase 2a $NKTR Phase 2b $CMPS Phase X $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $VIR Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $EGRX Phase 2/3 Check out the image for more details πΈ" @BiopharmIQ on X 2025-06-08 18:09:54 UTC 25.7K followers, 35.8K engagements
"π£ Biotech Stock News 07/08 @ Open 𧬠π° $PROK XXX% Topline Results for Phase X Trial $ZVSA XX% Supports FDA Emergency Use of VAR XXX $RLYB XX% Sells Interest in REV102 Program $PSTV XX% Initial Patients Treated in Dose Trial $HUMA XX% Symvess ECAT Approval from U.S. DLA $NBTX XX% Regulatory Harmonization and Patent Filed $RXRX XX% Acquires Full Rights to REV102 $LGVN X% FDA Approves IND for Pediatric DCM $ONCY X% Highlights Pelareorep Survival Data $LRMR X% Nonclinical Data on Nomlabofusp $RMTI X% Three-Year Partnership for Hemodialysis Supply $ETON X% FDA Accepts New Drug Application $CRGX" @BiopharmIQ on X 2025-07-08 15:06:21 UTC 25.7K followers, 4101 engagements
"𧬠Biopharma Weekly Recap π Interesting posts/ppl to check out π @BowTiedBiotech 1/ π« Mercks $10B Verona Bet: A Biotech Thread @Andre_AGTC $VRNA aquisition has positive effect on bios which are potential BO candidates $MDGL $MIRM $BBIO $SRRK $CRNX @JacobPlieth $VRNAs Enfisentirine Composition Patent Expired in 2020 Not a Concern for $MRK @LifeSciVC $MRK will acquire Verona Pharma $VRNA for $10B. Fun bit of biotech history. @A_May_MD Parallels Between $NKTR and $VRNA: Early-Stage Setup Market Potential and Sentiment Dynamics @doepke_michel $MDGL Positioned as Potential Takeover Target" @BiopharmIQ on X 2025-07-12 18:32:23 UTC 25.7K followers, 13.9K engagements
"π Biotech Stock News 7/7 @ Open 𧬠π° $COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses $URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling $NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -2%" @BiopharmIQ on X 2025-07-07 16:06:15 UTC 25.7K followers, 3437 engagements
"$ONC FDA approves tablet formulation of BRUKINSA (zanubrutinib) for all X approved indications π New tablets reduce pill burden & simplify dosing without compromising efficacy or safety β
Proven bioequivalent to capsules via Phase X crossover studies π Only BTK inhibitor offering flexible once or twice daily dosing π©Ί Only BTK inhibitor with recommended dosing for severe hepatic impairment BRUKINSA leads new CLL patient starts & is now top BTK inhibitor by U.S. market share See image for more details π" @BiopharmIQ on X 2025-06-12 19:42:12 UTC 25.7K followers, 2537 engagements
"July PDUFA Approval Decision Calendar Approval decisions for: $REGN $RHHBY $REPL $ASND $APLS $PTCT $KALV See details in our PDUFA calendar π
π" @BiopharmIQ on X 2025-06-30 14:37:16 UTC 25.7K followers, 23.4K engagements
"π Biotech Stock News 07/16 @ Open 𧬠π° $CGTX XX% Clinical Data from Ph2 Study $ONCY X% Aggregated Data on Pelareorep Effectiveness $CUE X% Complete Response Data in Ph1 Trial $RPTX X% Licensing Agreement for Lunresertib $VYGR X% Adds Fourth Alzheimer's Program to Pipeline $ADIL X% Regains Compliance with Nasdaq $KALV X% UK Approval of HAE Treatment $OGEN X% Manufacturing Agreement for ONP-002 Development $TMO -X% Strategic Partnership for Drug Manufacturing $BCDA -X% Patient Enrollment for CardiAMP HF Study $ENSC -X% Initiates Ph3 Study of PF614 $QNCX -X% Completes Enrollment in Phase 3" @BiopharmIQ on X 2025-07-16 16:16:20 UTC 25.7K followers, 2666 engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q3 2025. $PHVS Phase X $PHVS Phase X $NAMS Phase 2a $CGTX Phase X $DMAC Phase X $COGT Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $APGE Phase X $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase 3" @BiopharmIQ on X 2025-07-06 18:36:29 UTC 25.7K followers, 48.7K engagements
"𧬠Biotech Weekly News 7/14/25 - 7/18/25 Major Movers π π $TELO XX% Telomir-1 Update in Prostate Cancer $KAPA XX% Positive Results from Ph2 Trial $MEIP XX% $100M Private Placement $DARE XX% Ovaprene Interim Ph3 Results $RCKT XX% Receives RMAT Designation for Gene Therapy $SRPT -XX% FDA Shipment Halt Warning for Elevidys $CLSD -XX% Explore Strategic Alternatives for SCS Platform $BCLI -XX% Nasdaq Delisting & OTCQB Transition $ABOS -XX% Strategic Collab. for Alzheimer's Therapy $IKNA -X% Stockholder Approval of Merger See image below. πΈ π¨ $SRPT closed down XX% after reports of 3rd gene" @BiopharmIQ on X 2025-07-18 22:53:55 UTC 25.7K followers, 7191 engagements
"Interested in finding companies before they announce M&As πβ See our free M&A whispers report & see which could be next π" @BiopharmIQ on X 2025-07-22 14:39:05 UTC 25.7K followers, 1153 engagements
"Check out our catalyst calendar π & stay on top of key biopharma readouts π
π $XBI $IBB" @BiopharmIQ on X 2025-07-11 21:58:58 UTC 25.7K followers, 1243 engagements
"VR Adviser LLC-Bio Hedge Fund Q1 Holdings Top Holdings: $VRDN $COGT $ELVN $TERN $PLRX $AMAM $GHRS $DICE $KALV $MRUS $CELC $AVTE $CABA $VECT $ANNX $SVRA $MIST $ACRS $THRX $TRVI $FULC More details in the image:" @BiopharmIQ on X 2023-05-15 21:52:29 UTC 25.7K followers, 2968 engagements
"Biotech News 4/17π° $RXDX XX% Acquired by $MRK $XXXX B $STSA XX% Acquired by $SNBL $PCVX XX% Ph2 &Ph1/2 data $PIRS XX% Ph1 data @AACR'23 $MRUS XX% Ph1/2 interim data $PRAX X% Upcoming data presentations $CRVS X% New data @AACR'23 $INO X% Ph1b data @ECCMID'23 $ACAD X% Commercial Launch $AFMD X% Ph2 final data @AACR'23 $RNA X% Data upcoming @AAN'23 $XBIT X% Enrolled in Ph1 $VACC X% Ph1/2 interim data $ABCL X% New data @AACR'23 $MOR -X% Ph2 data @AACR'23 $IFRX -X% $40M Offering $GRTS -X% Ph1 data @ECCMID'23 $ALLO -X% Interim data @AACR'23 $AXLA -X% Ph2 Data @ECCMID'23 $XBI $XXXX XXX% $IBB $133.2" @BiopharmIQ on X 2023-04-17 17:49:41 UTC 25.7K followers, XX engagements
"𧬠Weekly Biotech Moves 7/7/25 - 7/11/25 $XBI: XXXX% ($87.02) π’ $IBB: XXXX% ($131.59) π’" @BiopharmIQ on X 2025-07-11 21:58:57 UTC 25.7K followers, 2430 engagements
"π’ M&A News: Theratechnologies $THTX Acquired by CB Biotechnology for up to $254M π€ π΅ $3.01/sh in cash + up to $1.19/sh CVR π $THTX up XX% at open π Expected to close during the Companys Q4 ending November XX 2025. See more information π πΈ" @BiopharmIQ on X 2025-07-03 14:42:08 UTC 25.7K followers, 10.8K engagements
"1/ π¨ $GSK AdCom is tomorrow 7/17 π§΅ π Belantamab mafodotin for r/r multiple myeloma β Ahead of meeting FDA raised safety concerns: π π© High rates of ocular toxicity incl. corneal damage & vision loss In DREAMM-7 & DREAMM-8: πΈ XX% of patients had eye toxicity (KVA events) πΈ 7778% had Grade XX events πΈ 70%+ had recurrent eye issues πΈ XX% still had unresolved eye toxicity at cutoff πΈ 7678% needed dose mods due to eye toxicity π© Dosing under fire: πΈ High toxicity despite adjusted regimens (2.5 mg/kg vs. XXX mg/kg) πΈ XX% remained on intended dose by Cycle X πΈ Limited dose optimization" @BiopharmIQ on X 2025-07-16 22:28:11 UTC 25.7K followers, 12.5K engagements
"π€ How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above $SRRK 8/34 π₯ $VRNA 7/34 π₯ $CRNX 7/34 π₯ $MDGL 6/34 π₯ $BPMC 5/34 π $PRME 5/34 π Access our FREE screener to check your fave stocks π" @BiopharmIQ on X 2025-07-12 18:37:09 UTC 25.7K followers, 3087 engagements
"𧬠Weekly Biotech Moves 6/30/25 - 7/3/25 $XBI: XXXX% ($85.24) π’ $IBB: XXXX% ($130.00) π’" @BiopharmIQ on X 2025-07-04 17:54:38 UTC 25.7K followers, 3514 engagements
"Biotech Stock News 5/22 Mid-day π $HEPA XX% Positive Ph2 result #NASH $AVRO XX% Sale of Gene therapy program to Novartis $87.5M $VECT XX% Acquisition by $IRWD $17.00/share $AKBA XX% UK approval $KRYS XX% $160M private placement $INKT XX% Data presentation @ ATS 2023 $PSTX XX% Data Presentation @ISTH 2023 $AUTL X% Ph2 data @ASCO 2023 $ALPN X% Ph1 data @major conferences $IDYA X% IND cleared $CYTK X% New data @ International congress $ATNM X% Poster presentation @SNMMI 2023 $RYTM X% Collaboration w/Genpharm $XBIT X% Ph2 study authorized $BBIO X% Updated data @ASGCT 2023 $KRTX X% Data" @BiopharmIQ on X 2023-05-22 17:26:32 UTC 25.7K followers, 4952 engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2" @BiopharmIQ on X 2025-07-13 18:07:52 UTC 25.7K followers, 33.9K engagements
"$FBIO β CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA Showed significant clinical benefit in both CuHis-ET (early tx) and CuHis-LT (late tx) cohorts 75-79% reduction in risk of death compared to untreated Historical Control (HC-ET and HC-LT) arms increase in Median OS from XXX years to XXXX years in the ET cohort Prior results πΈ π 4/7" @BiopharmIQ on X 2025-07-15 23:06:24 UTC 25.7K followers, XXX engagements
"Each quarter we identify major catalyst events π₯³ Likely to move the stock +/- by XX% π π $MLTX Sonelokimab $LRMR Nomlabofusp (CTI-1601) $IFRX INF904 Access our FREE Big Mover Report π" @BiopharmIQ on X 2025-07-20 20:51:43 UTC 25.7K followers, XXX engagements
"π Baker Bros. Q1 25* Holdings Released. π³ Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXX% π Top Holdings: $ONC $INCY $ACAD $MDGL $SMMT $INSM $RYTM $RVMD $KYMR $ALKS $EWTX $REPL $INSM $IMVT $BCYC $IMCR $KNSA $ABCL $RARE $DNLI *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details πΈπ" @BiopharmIQ on X 2025-05-15 22:05:13 UTC 25.7K followers, 20.7K engagements
"6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts in Q3 XX π π See π§΅ for more details about each asset/readout π $ARCT (Mid-2025) ARCT-032 / Cystic Fibrosis / Phase X $IONS (August XX 2025) Donidalorsen / Hereditary angioedema / PDUFA $FBIO (September XX 2025) β CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA $KALA (Q3 2025) KPI-012 / Persistent Corneal Epithelial Defect / Phase 2b $HRMY (Q3 2025) Zygel (ZYN002 CBD Gel) / Fragile X syndrome / Phase X $LRMR (September 2025) β Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X β = Expected big stock move confirmed by" @BiopharmIQ on X 2025-07-15 23:06:20 UTC 25.7K followers, 8833 engagements
"Let's see how many of the XX biopharma-focused hedge funds hold these tickers (5 is π₯). $MLTX 7/34 π₯ $LRMR 4/34 $IFRX 1/34 Access our FREE hedge fund screener & search your fav tickers π" @BiopharmIQ on X 2025-07-20 20:51:43 UTC 25.7K followers, XXX engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q4 2024 (1/4). $IMMP Phase X $AVIR Phase X $ABUS Phase 2a $ABUS Phase 2a $BRNS Phase 2b $VIR Phase X $DRRX Phase 2b $PLRX Phase 2a $AKRO Phase 2b $CRDL Phase X $ALGS Phase 2a $SYRS Phase X $IKT Phase X $ANAB Phase 2b $BMEA Phase 2b $GALT Phase 2b/3 $BMEA Phase X $MRUS Phase X $KROS Phase X $ADCT Phase X $AFMD Phase X $COGT Phase X $HCM Phase X $ADCT Phase X $SLS Phase 2a $AGIO Phase X $KROS Phase X $COGT Phase X $GLYC Phase X $LLY Phase X $ACLX Phase X $CLRB Phase X $LLY Phase X $BCTX Phase X $JAGX Phase X Check out the image for" @BiopharmIQ on X 2024-11-10 20:15:26 UTC 25.7K followers, 17.2K engagements
"Each quarter we identify major catalyst events π₯³ Likely to move the stock XX% or more π π $KZIA Paxalisib Ph2/3 $ATAI RL-007 Ph2b $CRNX Paltusotine PDUFA $INMB INKmune Ph2 and more π Access our FREE Big Mover Report π" @BiopharmIQ on X 2025-07-18 22:58:52 UTC 25.7K followers, 1641 engagements
"Biotech Stock Catalyst Watchlist π π― Ph2 & Ph3 readouts in Q2/H1 2025. $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $ARCT Phase X $PROK Phase X $ANRO Phase X $SPRO Phase X $INMB Phase X $CRDL Phase X $ATAI Phase X $INMB" @BiopharmIQ on X 2025-06-22 18:51:38 UTC 25.7K followers, 20.6K engagements
"π£ Biotech Stock News 07/17 @ Open $SRPT XX% Strategic Restructuring & Pipeline Update $RCKT XX% Receives RMAT Designation for Gene Therapy $MBRX XX% Explores Accelerated Strategic Partnerships $DMAC X% Positive Interim Phase X Results $MAIA X% Peer-Reviewed Pub. on Anticancer Prodrugs $AGEN X% FDA Approves SHINGRIX Prefilled Syringe $XXII X% Launch Confirms Viability of Nicotine Mandate $DNA X% Launches ADME Profiling Service $SDGR X% Expand Research Collaboration on JAK Target $PRAX X% FDA Breakthrough Therapy for Relutrigine $CYBN X% UK Approval for EMBRACE Study $NKGN X% New Funding for" @BiopharmIQ on X 2025-07-17 15:39:41 UTC 25.7K followers, 9530 engagements
"1/ π¨ PDUFA Pulse: π Whats on the FDA Radar This July π $REGN: Lynozyfic Approved β
$RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat Check out the July PDUFA calendar. π
π π‘ Cantor initiates coverage on $REPL ahead of July XX PDUFA full context below from @Quantumup1" @BiopharmIQ on X 2025-07-02 19:55:37 UTC 25.7K followers, 21.7K engagements
"$GSK π£ FDAs ODAC votes against belantamab mafodotin combos in R/R multiple myeloma β XX vote against BVd (with bortezomib) πππππ vs. πππ β XX vote against BPd (with pomalidomide) πππππππ vs. π β Reason: High ocular toxicity & poor tolerability despite PFS gains in DREAMM-7/8 FDA questioned dosage selection & real-world relevance of trial data Committee urged exploration of lower more tolerable doses π A tough call: Strong efficacy but stronger toxicity concerns" @BiopharmIQ on X 2025-07-17 21:33:21 UTC 25.7K followers, 5640 engagements
"$LRMR β Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X Generally well tolerated Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells) FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing Prior results πΈ π 7/7" @BiopharmIQ on X 2025-07-15 23:06:29 UTC 25.7K followers, 2099 engagements
"$GSK $AGEN π FDA approves GSKs SHINGRIX in a prefilled syringe Simplifies administration no vial reconstitution needed π Based on data showing technical comparability to current 2-vial version Supports easier delivery for healthcare professionals π― 1M people develop shingles in the US annually" @BiopharmIQ on X 2025-07-17 17:05:30 UTC 25.7K followers, 3770 engagements
"Biotech News 6/29 @ close π $SGTX XXX% Acquire by $LLY $14.92/sh $ENDPQ XX% Generic launch $FBIO X% Ph1 Dotinurad data $SGMO X% Licensing agrmnt w/ VYGR $MRUS X% BTD granted $ALDX X% Ph2 ADX2191 data $MNOV X% Presentation at RSA $LLY X% Acquire $SGTX $IRWD X% Completion of tender offer $BNTX X% Initiate Ph3 $AQST X% Submitted Libervant NDA $VECT X% Completion of tender offer $AZN X% Liver cancer ph3 data $AUPH X% Strategic alternatives (sale) $PTCT -X% Data from MIT-E $GERN -X% Expanded access $AKBA -X% Ph4 IMPACT data $PSTV -X% Interim updates $VYGR -X% Licensing agrmnt w/ $SGMO $CRVS -5%" @BiopharmIQ on X 2023-06-29 21:24:55 UTC 25.7K followers, 12.5K engagements
"Each quarter we identify major catalyst events π₯³ Likely to move the stock +/- by XX% π π Prev. Qtr Movers: π’ $LYRA XXXXXX% π’ $NKTR XXXXXX% π΄ $IFRX -XXXXX% π΄ $PRTA -XXXXX% Access our free Big Mover Report π" @BiopharmIQ on X 2025-07-15 23:06:30 UTC 25.7K followers, 2164 engagements
"Each quarter we identify major catalyst events π₯³ Likely to move the stock XX% or more π π $KZIA Paxalisib Ph2/3 $ATAI RL-007 Ph2b $CRNX Paltusotine PDUFA and more π Access our FREE Big Mover Report π" @BiopharmIQ on X 2025-07-04 18:03:37 UTC 25.7K followers, 1635 engagements
"π Biotech Stock News 7/14 @ Open $DARE XX% Ovaprene Interim Phase X Results $RANI XX% Bioequivalence of Novel Oral Agonist $EPIX X% Acquired by Xenotherapeutics $AMLX X% New Analyses from Ph2 Trials $CRNX X% New Long-Term Data on Paltusotine $VSTM X% Publication of Ph2 RAMP XXX Results $GILD X% New Data on Lenacapavir for HIV $RYTM X% Data on MC4R Agonists at ENDO 2025 $NBIX X% One-Year Data on CRENESSITY Efficacy $RARE X% Approval Extended for HoFH Treatment $RARE X% CRL for UX111 AAV Gene Therapy $PHGE X% Ph2b Trial for BX004 Initiated $CORT X% NDA for Relacorilant $CELC X% New Patent for" @BiopharmIQ on X 2025-07-14 16:27:05 UTC 25.7K followers, 3801 engagements
"Biotech Stock News 8/8 @ Open π $CRDF XX% Lead program update $INAB X% R&D facility $AMRN X% Commercial agreement $COCP X% Norovirus lead selected $JAGX X% Partners IND $RXRX X% Protein target prediction $ONCY -X% $15M public offering $EOLS -X% New Jeuveau branding $LSTA -X% ODD granted $PRAX -X% Long-term data $EBS -X% Cost reduction Full #biotech news in image below: π·" @BiopharmIQ on X 2023-08-08 16:08:45 UTC 25.7K followers, 3632 engagements
"π£ Biotech Stock News 07/15 @ Open 𧬠π° $KAPA XX% Positive Safety Results from Phase X Trial $PROK X% Alignment with FDA on Approval Pathway $LSTA X% Expands Intellectual Property Portfolio $CTXR X% Expands Distribution Network for LYMPHIR $CVM X% Closing of $XXX Million Offering $SLS X% Meets Primary Endpoints in Phase X Trial $ADAG X% Regulatory Update on Clinical Development $ATRA X% Transfer of Investigational New Drug Application $AEMD X% Positive Data Review for Next Trial $AQST X% International Expansion Update for Anaphylm $PYPD -X% Long-Acting GLP-1 Delivery Platform $GH -X% First" @BiopharmIQ on X 2025-07-15 16:02:39 UTC 25.7K followers, 4572 engagements
"𧬠Biopharma Weekly Recap π Interesting posts/ppl to check out π @ohadhammer New Jefferies Report Explores Chinas Biotech Ecosystem @BowTiedBiotech Great figure from Oppenheimer team on The China Trade @BioStocks $MDGL Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra. @seedy19tron Oral hearing for the $NKTR $LLY case @GeneInvesting REMEMBER $NTLA @yaireinhorn David Liu Warns of Impact from NIH Funding Cuts on U.S. Science @Prof_Oak_ $PRME proposing to reprice 8.3M options on the back of a 300%+ bounce from May lows @adamfeuerstein Leadership" @BiopharmIQ on X 2025-07-19 22:30:13 UTC 25.7K followers, 16.7K engagements
"π£ Biotech Stock News 07/22 @ Open $CRDL XX% Database Lock for Phase X Trial $CNTB XX% Appoints Industry Veteran to Board $STRO X% Research Collab. to Advance Standards $CGEM X% Acceptance of Abstracts for Zipalertinib $BIIB X% Highlighting Progress in Alzheimer's Disease $EHTH X% Achieves HITRUST i1 Certification $AZN X% Plans $50B investment in America $PCRX X% Strategic Collaboration to Expand Promotion $SRPT X% Voluntary Pause of ELEVIDYS Shipments $NAMS X% Presenting Alzheimer's Biomarker Data $DARE X% Webinar on DARE to PLAY Difference $OCUL X% Participation in Scientific Conferences" @BiopharmIQ on X 2025-07-22 15:47:12 UTC 25.7K followers, 4181 engagements
/creator/twitter::811036897883492352/posts